Fig. 6From: Cancer-associated fibroblast-derived gene signatures predict radiotherapeutic survival in prostate cancer patientsCorrelation analysis of the BCRFS-related CAF signature with various clinical characteristics of patients with prostate cancer based on GSE116918 and TCGA datasets. A Correlation analysis of risk score with gleason grade. B Correlation analysis of risk score with PSA. C Correlation analysis of risk score with clinical T stage and pathologic T stage. CAF: cancer-associated fibroblast; BCRFS: biochemical recurrence-free survival; PSA: prostate specific antigenBack to article page